Search Within

Lisa Bodei

  1. "Survivorship Research"
Formats
  1. Meeting Abstract (4)
  2. Journal Article (2)
  3. Editorial (1)
Groups
  1. Molecular Imaging and Therapy Service (7)
  2. Radiology, Department of (7)
  3. Sloan Kettering Institute Postdocs (7)
  4. Survivorship Research (7)
  5. Biostatistics Service (5)
  6. Department of Medicine (5)

More Groups

People
  1. Heiko Schoder (5)
  2. John Humm (4)
  3. Ryan Reddy (4)
  4. Brandon Imber (3)
  5. Christopher Riedl (3)
  6. Diane Reidy (3)

More People

Years
  1. 2024 (1)
  2. 2023 (3)
  3. 2022 (2)
  4. 2021 (1)
Publications
  1. Journal of Nuclear Medicine (2)
  2. European Journal of Nuclear Medicine and Molecular Imaging (1)
  3. International Journal of Radiation Oncology, Biology, Physics (1)
  4. Journal of Clinical Oncology (1)
  5. Neuroendocrinology (1)
  6. Pancreas (1)
Publishers
  1. Society of Nuclear Medicine (2)
  2. American Society of Clinical Oncology (1)
  3. Elsevier Inc. (1)
  4. Lippincott Williams & Wilkins (1)
  5. S. Karger AG (1)
  6. Springer (1)

Results (7)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Toward individualized dosimetry for radiopharmaceutical therapy in day-to-day clinical practice of nuclear oncology: Overcoming heterogeneity of radiation-absorbed dose to tumor and critical organs
    Editorial

    Bodei, L.; Tuttle, R. M.; Grewal, R. K.; Mauguen, A.; Augensen, F.; Abusamra, M.; Mahajan, S.; Jayaprakasam, V. S.; Osborne, J. R.; Haque, S.; more...
    European Journal of Nuclear Medicine and Molecular Imaging (2024)

    Fulltext@MSK | Save
  • Index lesion dosimetry for (177)Lu-PSMA-617 radiopharmaceutical therapy combined with stereotactic body radiotherapy in patients with oligometastatic castration-sensitive prostate cancer
    Meeting Abstract

    Grkovski, M.; O'Donoghue, J.; Imber, B.; Andl, G.; Tu, C.; Lafontaine, D.; Schwartz, J.; Thor, M.; Zelefsky, M.; Humm, J.; more...
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • Lesion dosimetry for [(177)Lu]Lu-PSMA-617 radiopharmaceutical therapy combined with stereotactic body radiotherapy in patients with oligometastatic castration-sensitive prostate cancer
    Journal Article

    Grkovski, M.; O'Donoghue, J. A.; Imber, B. S.; Andl, G.; Tu, C.; Lafontaine, D.; Schwartz, J.; Thor, M.; Zelefsky, M. J.; Humm, J. L.; more...
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • A pilot study of stereotactic body radiotherapy and (177)Lu-PSMA-617 for oligometastatic hormone sensitive prostate cancer
    Meeting Abstract

    Imber, B. S.; Bodei, L.; Humm, J.; Ionescu, A.; Wu, W.; Grkovski, M.; O'Donoghue, J.; Reddy, R. P.; Rimner, A.; Shasha, D.; more...
    International Journal of Radiation Oncology, Biology, Physics (2023)

    Fulltext@MSK | Save
  • Treatment response and clinical outcomes of well-differentiated high-grade neuroendocrine tumors to lutetium-177-DOTATATE
    Journal Article

    Raj, N.; Coffman, K.; Le, T.; Do, R. K. G.; Rafailov, J.; Choi, Y.; Chou, J. F.; Capanu, M.; Dunphy, M.; Fox, J. J.; more...
    Neuroendocrinology (2022)

    Fulltext@MSK | Save
  • Treatment response and clinical outcomes of well-differentiated (WD) high-grade (HG) neuroendocrine tumors (NETs) to (177)Lu-DOTATATE
    Meeting Abstract

    Coffman, K.; Bodei, L.; Le, T.; Choi, Y.; Chou, J.; Capanu, M.; Dunphy, M.; Fox, J.; Grewal, R.; Reddy, R.; more...
    Pancreas (2022)

    Fulltext@MSK | Save
  • Treatment response and clinical outcomes of well-differentiated high-grade neuroendocrine tumors to 177Lu-DOTATATE
    Meeting Abstract

    Coffman, K. L.; Bodei, L.; Le, T.; Choi, Y.; Chou, J. F.; Capanu, M.; Dunphy, M.; Fox, J. J.; Grewal, R. K.; Reddy, R.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save